loadpatents
Patent applications and USPTO patent grants for KATSUMOTO; Tamiko.The latest application filed is for "methods of treating rheumatoid arthritis, chronic spontaneous urticaria, and systemic lupus erythematosis using an inhibitor of bruton's tyrosine kinase".
Patent | Date |
---|---|
Methods Of Treating Rheumatoid Arthritis, Chronic Spontaneous Urticaria, And Systemic Lupus Erythematosis Using An Inhibitor Of Bruton's Tyrosine Kinase App 20220047588 - KATSUMOTO; Tamiko ;   et al. | 2022-02-17 |
Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulators Grant 11,034,698 - Bryan , et al. June 15, 2 | 2021-06-15 |
IRAK4 modulators Grant 10,899,774 - Bryan , et al. January 26, 2 | 2021-01-26 |
IRAK4 modulators Grant 10,899,772 - Bryan , et al. January 26, 2 | 2021-01-26 |
PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS App 20200123166 - BRYAN; Marian C. ;   et al. | 2020-04-23 |
Irak4 Modulators App 20200115388 - BRYAN; Marian C. ;   et al. | 2020-04-16 |
Irak4 Modulators App 20200115383 - BRYAN; Marian C. ;   et al. | 2020-04-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.